phase 2_completion
saveNational Heart Lung and Blood Institute — danazol (Phase II Trial Completion)
community read0 votes
Therapy area: Gastrointestinal, Genetic Disorders, Hematological Disorders, Respiratory. Indication: Cytopenia, Liver Fibrosis, Mutational Disorders, Pulmonary Fibrosis
comments(0)
5-min edit window · permanent after that